Full metadata record
DC FieldValueLanguage
dc.contributor.authorSchorning, Kirsten-
dc.contributor.authorKonstantinou, Maria-
dc.date.accessioned2017-11-14T13:23:20Z-
dc.date.available2017-11-14T13:23:20Z-
dc.date.issued2017-
dc.identifier.urihttp://hdl.handle.net/2003/36181-
dc.identifier.urihttp://dx.doi.org/10.17877/DE290R-18197-
dc.description.abstractThe issue of determining not only an adequate dose but also a dosing frequency of a drug arises frequently in Phase II clinical trials. This results in the comparison of models which have some parameters in common. Planning such studies based on Bayesian optimal designs offers robustness to our conclusions since these designs, unlike locally optimal designs, are efficient even if the parameters are misspecified. In this paper we develop approximate design theory for Bayesian D-optimality for nonlinear regression models with common parameters and investigate the cases of common location or common location and scale parameters separately. Analytical characterisations of saturated Bayesian D-optimal designs are derived for frequently used dose-response models and the advantages of our results are illustrated via a numerical investigation.en
dc.language.isoende
dc.relation.ispartofseriesDiscussion Paper / SFB823;22/2017en
dc.subject.ddc310-
dc.subject.ddc330-
dc.subject.ddc620-
dc.titleBayesian optimal designs for dose-response curves with common parametersen
dc.typeTextde
dc.type.publicationtypeworkingPaperde
dcterms.accessRightsopen access-
eldorado.secondarypublicationfalsede
Appears in Collections:Sonderforschungsbereich (SFB) 823

Files in This Item:
File Description SizeFormat 
DP_2217_SFB823_Schorning_Konstantinou.pdfDNB362.31 kBAdobe PDFView/Open


This item is protected by original copyright



This item is protected by original copyright rightsstatements.org